Literature DB >> 22547841

Factors influencing complete tumor excision of mast cell tumors and soft tissue sarcomas: a retrospective study in 100 dogs.

Beatriz Monteiro1, Sarah Boston, Gabrielle Monteith.   

Abstract

The recommended treatment for soft tissue sarcomas (STS) and mast cell tumors (MCT) is complete surgical removal, provided that the tumor is amenable to surgical excision. The objective of this study was to evaluate possible risk factors for incomplete surgical excision of skin and subcutaneous STS and MCT in 100 dogs treated with wide excision with curative intent. Decreased body weight was a risk factor (P = 0.03, odd's ratio = 0.96) as well as increased tumor size (1.4% increase in risk of incomplete excision per cm(2); P = 0.02). Gender, age, breed, location, grade, tumor type, re-excision, and level of surgeon's training (P = 0.0711) were not significant. Veterinary surgery residents were at increased risk of incompleteness of excision compared with ACVS surgeons and ACVS surgeons with additional training in surgical oncology.

Entities:  

Mesh:

Year:  2011        PMID: 22547841      PMCID: PMC3196013     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  33 in total

1.  Variation among pathologists in histologic grading of canine cutaneous mast cell tumors.

Authors:  Nicole C Northrup; Barry G Harmon; Tracy L Gieger; Cathy A Brown; K Paige Carmichael; Anapatricia Garcia; Kenneth S Latimer; John S Munday; Pauline M Rakich; Lauren J Richey; Nancy L Stedman; An-Lin Cheng; Elizabeth W Howerth
Journal:  J Vet Diagn Invest       Date:  2005-05       Impact factor: 1.279

Review 2.  Soft-tissue sarcomas in dogs: a review.

Authors:  Nicole Ehrhart
Journal:  J Am Anim Hosp Assoc       Date:  2005 Jul-Aug       Impact factor: 1.023

3.  Evaluation of prognostic factors associated with outcome in dogs with multiple cutaneous mast cell tumors treated with surgery with and without adjuvant treatment: 54 cases (1998-2004).

Authors:  Marie N Mullins; William S Dernell; Stephen J Withrow; Eugene J Ehrhart; Douglas H Thamm; Susan E Lana
Journal:  J Am Vet Med Assoc       Date:  2006-01-01       Impact factor: 1.936

4.  The importance of the mitotic index as a prognostic factor for survival of canine cutaneous mast cell tumors: a validation study.

Authors:  Lilian B Elston; Felipe A R Sueiro; Josemara N Cavalcanti; Konradin Metze
Journal:  Vet Pathol       Date:  2009-03       Impact factor: 2.221

5.  Evaluation of a two-centimeter lateral surgical margin for excision of grade I and grade II cutaneous mast cell tumors in dogs.

Authors:  Ryan P Fulcher; Lori L Ludwig; Philip J Bergman; Shelley J Newman; Amelia M Simpson; Amiya K Patnaik
Journal:  J Am Vet Med Assoc       Date:  2006-01-15       Impact factor: 1.936

6.  Evaluation of primary re-excision after recent inadequate resection of soft tissue sarcomas in dogs: 41 cases (1999-2004).

Authors:  Nicholas J Bacon; William S Dernell; Nicole Ehrhart; Barbara E Powers; Stephen J Withrow
Journal:  J Am Vet Med Assoc       Date:  2007-02-15       Impact factor: 1.936

7.  Marginal excision of low-grade spindle cell sarcoma of canine extremities: 35 dogs (1996-2006).

Authors:  Damiano Stefanello; Emanuela Morello; Paola Roccabianca; Selina Iussich; Claudia Nassuato; Marina Martano; Chiara Squassino; Giancarlo Avallone; Stefano Romussi; Paolo Buracco
Journal:  Vet Surg       Date:  2008-07       Impact factor: 1.495

8.  Mitotic index is predictive for survival for canine cutaneous mast cell tumors.

Authors:  E M Romansik; C M Reilly; P H Kass; P F Moore; C A London
Journal:  Vet Pathol       Date:  2007-05       Impact factor: 2.221

9.  Clinical problems after initial unplanned resection of sarcoma.

Authors:  Manabu Hoshi; Makoto Ieguchi; Masatsugu Takami; Masanari Aono; Susumu Taguchi; Takaaki Kuroda; Kunio Takaoka
Journal:  Jpn J Clin Oncol       Date:  2008-10       Impact factor: 3.019

Review 10.  Advances in the diagnosis and management of cutaneous mast cell tumours in dogs.

Authors:  J M Dobson; T J Scase
Journal:  J Small Anim Pract       Date:  2007-06-09       Impact factor: 1.522

View more
  3 in total

1.  Aggressive local therapy combined with systemic chemotherapy provides long-term control in grade II stage 2 canine mast cell tumour: 21 cases (1999-2012).

Authors:  A Lejeune; K Skorupski; S Frazier; I Vanhaezebrouck; R B Rebhun; C M Reilly; C O Rodriguez
Journal:  Vet Comp Oncol       Date:  2013-05-31       Impact factor: 2.613

2.  Evaluation of Tumor Grade and Proliferation Indices before and after Short-Course Anti-Inflammatory Prednisone Therapy in Canine Cutaneous Mast Cell Tumors: A Pilot Study.

Authors:  Shawna Klahn; Nikolaos Dervisis; Kevin Lahmers; Marian Benitez
Journal:  Vet Sci       Date:  2022-06-07

3.  A systematic review of surgical margins utilized for removal of cutaneous mast cell tumors in dogs.

Authors:  Laura E Selmic; Audrey Ruple
Journal:  BMC Vet Res       Date:  2020-01-06       Impact factor: 2.741

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.